Cetuximab plus chemoradiation with cisplatin and 5-fluorouracil (5-FU) in locally advanced unresectable esophageal squamous cell carcinoma.

被引:0
|
作者
Sunpaweravong, P.
Sunpaweravong, S.
Sangthawan, D.
Pinaikul, S.
Attasaranya, S.
Dechaphunkul, A.
Mitarnun, W.
Fungthammasarn, T.
机构
[1] Prince Songkla Univ, Div Med Oncol, Holist Ctr Canc Study & Care HOCC PSU, Hat Yai, Thailand
[2] Dept Surg, Songkhla, Thailand
[3] Dept Radiol, Songkhla, Thailand
[4] Dept Med, Songkhla, Thailand
[5] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[6] Dept Pathol, Songkhla, Thailand
[7] Holist Ctr Canc Study & Care, Songkhla, Thailand
关键词
D O I
10.1200/jco.2011.29.15_suppl.e14548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14548
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Cetuximab plus 5-fluorouracil (5-FU) in advanced cutaneous squamous cell carcinoma: A retrospective analysis
    Huynh, J.
    Eigentler, T.
    Moritz, R.
    Schlaak, M.
    Dobos, G.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 71 - 71
  • [2] Phase I Study of Definitive Chemoradiation With Cisplatin/5-FU Plus Cetuximab in Unresectable Esophageal Cancer
    Rades, D.
    Moehler, M. H.
    Schmidberger, H.
    Fellermann, K.
    Buerk, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S450 - S450
  • [3] Phase I study of cetuximab (CET) in combination with 5-fluorouracil (5-FU), cisplatin (CP), and radiotherapy (RT) in patients with locally advanced squamous cell anal carcinoma (LAAC)
    Olivatto, L. O.
    Meton, F.
    Bezerra, M.
    Cardoso, A.
    Araujo, C. M.
    Castro, L.
    Moura, R.
    Pereira, V.
    Ferreira, C. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer
    Almhanna, Khaldoun
    Hoffe, Sarah
    Strosberg, Jonathan
    Dinwoodie, William
    Meredith, Kenneth
    Shridhar, Ravi
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (01) : 39 - 44
  • [5] Preoperative chemoradiation with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma.
    Alonso, V
    Salud, A
    Escudero, P
    Valencia, J
    Mira, M
    de Lobera, AR
    Lambea, J
    Grandez, R
    Tres, A
    Anton, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 271S - 271S
  • [6] Chemoradiation with intensity modulated radiotherapy (IMRT) and cisplatin/5-FU for patients with locally advanced squamous cell carcinoma of the esophagus
    Krempien, R.
    Munter, M.
    Werner, J.
    Jensen, A.
    Steuber, E.
    Huber, P.
    Debus, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 132 - 132
  • [7] A RANDOMIZED TRIAL OF CISPLATIN (CACP) + 5-FLUOROURACIL (5-FU) INFUSION AND CACP + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, JA
    ENSLEY, JF
    JACOBS, J
    WEAVER, A
    CUMMINGS, G
    ALSARRAF, M
    [J]. CANCER, 1985, 56 (12) : 2740 - 2744
  • [8] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Wing-Lok Chan
    Cheuk-Wai Choi
    Ian Yu-Hong Wong
    Terence Hon-Ting Tsang
    Adrian Tin-Chung Lam
    Rosa Pui-Ying Tse
    K. K. Chan
    Claudia Wong
    Betty Tze-Ting Law
    Emina Edith Cheung
    Siu-Yin Chan
    Ka-On Lam
    Dora Kwong
    Simon Law
    [J]. Annals of Surgical Oncology, 2023, 30 : 861 - 870
  • [9] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    Choi, Cheuk-Wai
    Wong, Ian Yu-Hong
    Tsang, Terence Hon-Ting
    Lam, Adrian Tin-Chung
    Tse, Rosa Pui-Ying
    Chan, K. K.
    Wong, Claudia
    Law, Betty Tze-Ting
    Cheung, Emina Edith
    Chan, Siu-Yin
    Lam, Ka-On
    Kwong, Dora
    Law, Simon
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 861 - 870
  • [10] 5-FU induced encephalopathy during 5-FU containing regimen for esophageal squamous cell carcinoma.
    Kato, Ken
    Akiyoshi, Kohei
    Hokamura, Nobukazu
    Igaki, Hiroyasu
    Tachimori, Yuji
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)